We are live on ! Find out more
DAM

Doheny Asset Management Portfolio holdings

AUM $153M
1-Year Est. Return 42.04%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+42.04%
3 Year Est. Return
+121.4%
5 Year Est. Return
10 Year Est. Return
AUM
$184M
AUM Growth
-$6.02M
Cap. Flow
-$10.5M
Cap. Flow %
-5.67%
Top 10 Hldgs %
39.53%
Holding
108
New
5
Increased
12
Reduced
54
Closed
8

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$2.64M
2
NMRK icon
Newmark Group
NMRK
+$2.07M
3
SBUX icon
Starbucks
SBUX
+$2M
4
KYNB
Kyntra Bio
KYNB
+$1.7M
5
AAPL icon
Apple
AAPL
+$1.26M

Sector Composition

Rank Sector Weight
1 Technology 24.88%
2 Healthcare 14.44%
3 Energy 14%
4 Financials 12.58%
5 Real Estate 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$13.7M 7.43%
296,156
-27,820
-9% -$1.26M
RITM icon
2
Rithm Capital
RITM
$5.52B
$9.7M 5.26%
554,600
-19,550
-3% -$343K
BGC icon
3
BGC Group
BGC
$5.52B
$9.16M 4.97%
1,258,132
+164,889
+15% +$1.32M
WATT icon
4
Energous
WATT
$77.6M
$7.71M 4.18%
867
-24
-3% -$252K
MCHP icon
5
Microchip Technology
MCHP
$40.3B
$6.64M 3.6%
146,120
-10,150
-6% -$470K
SFL icon
6
SFL Corp
SFL
$1.64B
$6.36M 3.45%
425,550
+74,066
+21% +$1.08M
LXP icon
7
LXP Industrial Trust
LXP
$3.57B
$5.22M 2.83%
119,710
-4,680
-4% -$194K
BP icon
8
BP
BP
$116B
$4.94M 2.68%
115,012
+3,408
+3% +$143K
KPTI icon
9
Karyopharm Therapeutics
KPTI
$43.5M
$4.81M 2.61%
18,863
+3,597
+24% +$890K
JNJ icon
10
Johnson & Johnson
JNJ
$618B
$4.66M 2.52%
38,383
-1,200
-3% -$150K
BAC icon
11
Bank of America
BAC
$435B
$4.56M 2.47%
161,665
-23,300
-13% -$695K
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.36T
$4.42M 2.39%
79,140
-500
-0.6% -$27K
MPC icon
13
Marathon Petroleum
MPC
$92.4B
$4.09M 2.22%
58,350
-1,200
-2% -$91.6K
PSX icon
14
Phillips 66
PSX
$84.9B
$3.91M 2.12%
34,792
-2,310
-6% -$260K
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.36T
$3.89M 2.11%
68,820
-3,500
-5% -$190K
RESN
16
DELISTED
Resonant Inc.
RESN
$3.65M 1.98%
646,475
+541,815
+518% +$2.47M
MRK icon
17
Merck
MRK
$322B
$3.55M 1.93%
61,355
+6,026
+11% +$340K
INTC icon
18
Intel
INTC
$455B
$3.29M 1.79%
66,269
+24,987
+61% +$1.33M
KYNB
19
Kyntra Bio
KYNB
$27.2M
$3.19M 1.73%
2,035
-1,305
-39% -$1.7M
CHKP icon
20
Check Point Software Technologies
CHKP
$13B
$3.14M 1.7%
32,121
-1,575
-5% -$156K
NFLX icon
21
Netflix
NFLX
$299B
$2.85M 1.54%
72,700
CVX icon
22
Chevron
CVX
$392B
$2.8M 1.52%
22,138
+1,470
+7% +$182K
SRLP
23
DELISTED
SPRAGUE RESOURCES LP
SRLP
$2.52M 1.37%
99,400
-7,450
-7% -$175K
HALO icon
24
Halozyme
HALO
$9.79B
$2.5M 1.36%
148,480
-14,670
-9% -$277K
CMBT
25
CMB.TECH NV
CMBT
$4.69B
$2.43M 1.32%
263,800
-128,500
-33% -$1.13M

Similar funds

Doheny Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Doheny Asset Management held 108 positions worth $184M, down 3.2% from $190M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Doheny Asset Management withdrew a net $10.5M in Q2 2018, closing 8 positions and reducing 54 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $2.64M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Doheny Asset Management opened a new position in Solaris Energy Infrastructure worth $2.07M.

  • Doheny Asset Management's largest Q2 2018 buy was Solaris Energy Infrastructure: 144,950 shares worth $2.07M.
  • Doheny Asset Management added most to Resonant Inc. in Q2 2018, an estimated $2.47M increase.
  • Doheny Asset Management's biggest Q2 2018 reduction was Newmark Group, cutting an estimated $2.07M.
  • Doheny Asset Management fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $2.64M.
  • Doheny Asset Management's ten largest holdings make up 40% of its $184M portfolio in Q2 2018.
  • Doheny Asset Management opened 5 new positions and closed 8 in Q2 2018.
  • Doheny Asset Management's portfolio value fell 3.2% quarter-over-quarter to $184M.

Based on Doheny Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.